Understanding how TIMP-1 affects influenza virus infections
Mechanistic Insights of TIMP-1 in Influenza Virus Infection
This study is looking at a protein called TIMP-1 to see how it affects people with severe flu and related complications, like pneumonia, in hopes of finding better treatments for the virus that could help patients feel better faster.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10615782 on NIH RePORTER |
What this research studies
This research investigates the role of TIMP-1, a protein that regulates certain enzymes, in the context of influenza A virus infections. It aims to understand how TIMP-1 levels change in patients with severe influenza and how these changes relate to complications like pneumonia and multi-organ failure. By studying the effects of TIMP-1 on immune responses and lung injury in animal models, the research seeks to identify new therapeutic targets for developing more effective antiviral treatments. Patients may benefit from insights that could lead to improved antiviral strategies against influenza.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced severe influenza infections or are at high risk for complications from the virus.
Not a fit: Patients who have mild influenza infections or those who are fully vaccinated and have robust immune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antiviral treatments for influenza, potentially reducing morbidity and mortality associated with the virus.
How similar studies have performed: While the role of TIMP-1 in other diseases has been studied, this specific investigation into its effects on influenza virus infections is novel and has not been extensively tested.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Wang, Xiaoyun — University of Georgia
- Study coordinator: Wang, Xiaoyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.